SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 469 filers reported holding SEAGEN INC in Q3 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,238,216 | -6.3% | 199,096 | -15.0% | 1.08% | +0.7% |
| Q2 2023 | $45,068,359 | -18.3% | 234,170 | -14.1% | 1.07% | -27.6% |
| Q1 2023 | $55,188,462 | +58.5% | 272,576 | +0.6% | 1.48% | +26.5% |
| Q4 2022 | $34,821,070 | -16.1% | 270,960 | -10.6% | 1.17% | -0.3% |
| Q3 2022 | $41,487,000 | -13.0% | 303,200 | +12.6% | 1.17% | -46.1% |
| Q2 2022 | $47,659,000 | +62.5% | 269,353 | +32.3% | 2.18% | +176.2% |
| Q1 2022 | $29,331,000 | -7.4% | 203,613 | -0.6% | 0.79% | +19.5% |
| Q4 2021 | $31,680,000 | -7.4% | 204,918 | +1.7% | 0.66% | +1.7% |
| Q3 2021 | $34,201,000 | -4.7% | 201,423 | -11.4% | 0.65% | +1.9% |
| Q2 2021 | $35,884,000 | -11.2% | 227,286 | -21.9% | 0.64% | -17.1% |
| Q1 2021 | $40,431,000 | -19.1% | 291,164 | +2.0% | 0.77% | -12.2% |
| Q4 2020 | $49,973,000 | – | 285,333 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |